Form 8-K - Current report:
SEC Accession No. 0001564590-20-052493
Filing Date
2020-11-09
Accepted
2020-11-09 16:07:43
Documents
3
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alt-8k_20201109.htm 8-K 37054
2 EX-99.1 alt-ex991_6.htm EX-99.1 340129
3 GRAPHIC gjasryxl5a3w000001.jpg GRAPHIC 8685
  Complete submission text file 0001564590-20-052493.txt   390623
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 201297726
SIC: 2834 Pharmaceutical Preparations